In 1960, the Brazilian’s life expectancy was 48 years. Today, almost 60 years later, reaches 75 years, according to data from the Brazilian Institute of Geography and Statistics (IBGE). If on one hand the longevity is a sign of social and economic development, on the other demand more investment in health care, as there is need for greater assistance during aging.
Thus, a major challenge in medicine is to ensure not only that the population live longer, but to live better. Given the challenge for the coming years, the medicine back his gaze to the technology, one of the areas where we can find an effective support. This was precisely the theme of the event technology to the Health Service, conducted by the newspaper O Globo and correalizado by Editora Globo. The meeting is the second of Intelligent Life series, which discusses the need for a new standard of technological and economic development in the country.
One of the participants in the debate, Carlos Alberto Goulart, chief executive of the Association of industry High technology health Products (ABIMED) said that the efficient use of technology in healthcare can help to reduce costs in every sector, and promote early diagnosis and more assertive treatments.
– Technology is an element of sustainability of the whole chain, because it creates more efficient service and reduce costs, besides being vector of economic development -. Goulart said
good example of the active use of new technologies in medicine is the remote monitoring of patients. Among other advantages, this feature reduces the length of hospital stay and the need to return often to the hospital, providing more comfort to the client. In addition, it broadens the service capacity of the establishment.
500 000 technology
According to Carlos Gouvea, president of the Brazilian Alliance Innovative Industry Health (ABIIS), there are more than 500,000 medical technologies different in use today, laboratory tests for the treatment of various cancers by molecular biology
-. New areas of knowledge such as genomics, pharmacogenomics and pharmacogenetics identify the propensity for certain diseases and allow the personalization of medicine, making public spending more efficient health – said
Paul Chapchap, director general and CEO of the Syrian-Lebanese Hospital in Sao Paulo, one of the most developed country medical centers. , highlighted the importance of early diagnosis, possible thanks to innovation.
breast cancer, he explains, can go through up to four stages. The diagnosis in phase one guarantees 95% cure rate. In the fourth stage, the number is reversed: the mortality rate is 95%. Hence the value of technology to medicine
-. Humanitarian gain the use of various technologies applied to medicine is indisputable, but we live the risk of getting better medicine for fewer people. This is the challenge we face: better management to increase access to much of the population to technology that transforms – said Chapchap on the need to popularize access to modern treatments
the Syrian-Lebanese Hospital has been implementing, in partnership with Siemens, new management models and the use of advanced equipment, which allow greater precision and sensitivity in early diagnosis of various diseases, reducing the cost of treatment and especially the suffering of the sick and their families
-. we need to consider new models of patient data integration to the existing technology in the country to help reduce costs, rework and waste – Chapchap said
for Armando Lopes, Country Head of Siemens Healthineers in Brazil, the technology is an instrument that can expand access to quality health care, and so should be seen as one. investment. Among the resources, he cited standardization procedures, minimally invasive procedures and intensive use of efficient management platforms, which increase productivity and preserve the humanization of care.
– In a cost pressure scenario in the entire chain, which a technology company can offer is clinical and operational excellence, as well as customized services. From a clinical point of view, it is possible to avoid the repetition of tests and better target treatments. With respect to operating, there are gains in productivity and cost optimization. – Said Lopes
Check participants event:
No comments:
Post a Comment